Medtronic Stock: A Deep Dive Into Analyst Perspectives (15 Ratings)
Portfolio Pulse from Benzinga Insights
Medtronic (NYSE:MDT) has been analyzed by 15 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target has increased by 3.64% to $94.73. Analysts have mostly raised their ratings, reflecting a positive sentiment shift. Medtronic's financials show a positive revenue trend and strong net margin, but challenges in ROE and ROA.
October 25, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Medtronic has seen a positive shift in analyst sentiment, with the average 12-month price target rising by 3.64% to $94.73. Analysts have predominantly raised their ratings, indicating a favorable outlook. Despite strong net margins, the company faces challenges with ROE and ROA.
The increase in the average price target and the majority of analysts raising their ratings suggest a positive short-term impact on Medtronic's stock price. The company's strong net margin supports this outlook, although challenges in ROE and ROA may temper long-term expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100